Danaher Completes Tender Offer for Beckman Coulter | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher reported after the close of the market on Friday that it's wholly owned subsidiary Djanet Acqusition has completed its tender offer for Beckman Coulter for $83.50 per share.

Separately, Danaher also said that it has issued a total of $1.1 billion in short-term promissory notes to finance part of the $6.8 billion deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.